Mature cystic teratomas (MCTs) are the most common germ cell tumors of the ovary. Malignant tranformation occurs in 1-2% of these neoplasms. Although most of the malignancies arising from MCTs are squamous cell carcinomas, adenocarcinoma of the gastrointestinal type is extremery rare. We herein present a case of adenocarcinoma of the intestinal type arising from a MCT.
A 49-year-old female underwent surgery for a left ovarian tumor. The histology of the cyst walls revealed a MCT with a few hair shafts and a squamous layer, while another part of the tumor showed adenocarcinoma of the intestinal type. Five years after surgery, she is alive without disease.
Malignant transformationMature cystic teratomaAdenocarcinomaIntestinal type
Mature cystic teratomas (MCTs) are the most common germ cell tumors of the ovary. MCTs comprise 18% of ovarian neoplasms, and malignant teranformation occurs in 1-2% of these neoplasms
 . Most of the malignancies arising from MCTs are squamous call carcinomas, with adenocarcinomas comprising only 7% of the malignant tumors
. Moreover, there have been few reports of adenocarcinoma of the gastrointestinal type in the ovary arising from a MCT
[2–5]. We herein present a case of ovarian adenocarcinoma of the intestinal type arising from a MCT in a perimenopausal female, and provide a review of the literature.
A 49-year-old female, gravida 5, para 3, presented with dysuria and hematuria. Her past medical, surgical, gynecological, and family histories were all unremarkable. Her menstrual cycle was irregular. A bimanual pelvic examination identified a movable mass in the left adnexal region. Vaginal ultrasound confirmed the presence of a polycystic mass of 67 x 57 mm in diameter without a solid component, suggestive of ovarian tumor (Figure
1). Ascites was absent, and there were no abnormal findings of the uterus and right adnexae. Magnetic resonance imaging (MRI) showed a multilocular cystic mass with a fat component (Figure
2). The serum tumor marker levels were within the normal ranges: CA125; 20.0U/mL (normal <35.0), CA19-9; 3.8 U/mL (normal <37.0), SCC; 1.1ng/mL (normal <1.5), except for carcinoembrionic antigen (CEA); 6.9ng/mL (normal <5.0). The diagnosis of left ovarian MCT was made based on these data, and laparoscopic surgery was planned.
An exploratory laparoscopy revealed an enlarged left ovary (80mm × 70mm). The surface of the tumor was smooth and well-circumscribed. There was no adherence to any other pelvic organs. A small amount of ascites was detected, and the cytology of ascites was negative for malignancy. A laparoscopic left salpingo-oophorectomy was performed, and the intraoperative diagnosis of frozen sections was suspicious of borderline malignancy. Therefore, we changed the procedure to a laparotomy and abdominal simple total hysterectomy, and a right salpingo-oophorectomy and partial omentectomy were carried out. The patient’s postoperative course was uneventful. The pathological findings revealed the tumor to be adenocarcinoma of the intestinal type arising from a MCT. The serum level of CEA was normalized 7 days after surgery. We explained to the patient that there was no evidence about the need for adjuvant therapy because the disease is extremely rare. She decided not to receive adjuvant therapy. The patient had no recurrence of the disease as of 5 years after the surgery.
Macroscopic and microscopic evaluations
Macroscopically, the resected ovarian mass was cystic and contained sebaceous material, hair, and calcification. The inner surface of the mass was rough, and had partial thicking-like nodules (Figure
3). The gross appearance of the uterus, right adnexae and omentum were normal. The microscopic examination of the ovarian mass revealed that the formation contained a lot of large and small cysts including mucin, cell debris and calcification. The cells which formed the lumen of cysts were mostly columnar epithelium, with some goblet cells (Figure
4). The consistency of the small glandular cavity was high, and severe dyskaryotic cells had become multilayered. The nuclei were enlarged and irregularly shaped and contained coarse chromatin, multidistributed and showed atypia. Most nuclei had a large and brightly nucleoli. In some areas, the malignant transformation of the intestinal epithelium resulted in a well-differentiated adenocarcinoma with stromal invasion (Figure
In the immunohistochemical staining studies, CK20 (Dako) and Muc-2 (Novocastra) were positive, and CK7 (Dako), Muc-5AC (Novocastra) (Figure
6), Muc-6 (Novocastra), the ER (Dako), and the PR (Dako) (Figure not shown) were negative in the adenocarcinomatous part. Another part of the cyst wall revealed a MCT with a few hair shafts, squamous layer and sebaceous gland (Figure
7). There were no immature components in the tumor.
The final diagnosis was left ovarian MCT with malignant transformation and mucinous adenocarcinoma, intestinal type, FIGO stage Ic (b).
Malignant transformation of MCTs has been recorded as occurring in 1-2% of cases
. The most common form of malignant transformation of MCTs is squamous cell carcinoma, which occurs in about 75% of cases, while adenocarcinoma arising from MCTs is rare, with an incidence of 7%
. Adenocarcinoma of the gastrointestinal type is extremely rare. The immunohistochemical analysis showed positive staining for CK20 and Muc-2, while CK7, Muc-5AC and Muc-6 were negative in the adenocarcinomatous part. Therefore, we diagnosed the tumor as adenocarcinoma of the intestinal type arising from a MCT. To our knowledge, only six cases of adenocarcinoma of the gastrointestinal type arising from MCTs have been reported in the English literature
[2–7]. The relevant clinical and pathological findings of these cases are summarized in Table
1. The patients’ ages ranged from 37 to 77 years old (mean, 50 years). All of the cases were of stage I disease, excluding the second patient. All patients had undergone surgery and had been diagnosed based on the postoperative histological findings. Two patients received adjuvant chemotherapy, but one patient died of disease 3 months after surgery.
Preveous reports of adenocarcinoma of the gastrointestinal type in the ovary arising from a MCT
*1 TAH: total abdominal hysterectomy, SO: salpingo-oophorectomy, OMT: omentectomy, PLN: pelvic lymphadenecomy, PAN: para aortic lymphadenectomy, *2 FAMT:5-furuorouracil+endoxan+mitomycin-C+toyomycin.
*3 N.E.: not examined *4 N.D.: no discription WNL : within normal limits.
MCTs of the ovary represent the majority of benign ovarian neoplasms in females younger than 30 years of age
, whereas malignant transformation of MCTs is usually found in postmenopausal females. The present case was perimenopausal and three of the six previous cases were premenopausal. Adenocarcinoma of the gastrointestinal type arising from MCTs may occur at a lower age than other histological types of malignant transformation of MCTs.
Recently, laparoscopic surgery for benign ovarian cystic tumors has been performed rather than laparotomy. However, there have been concerns about artificial tumor rupture due to chemical peritonitis and the spread of tumor cells. Hackethal et al.
 reviewed and analyzed the published data about squamous cell carcinoma arising from MCTs of the ovary. According to their data, unlike common ovarian carcinomas, rupture of the tumor capsule has no adverse prognostic effects. In the present case, we performed a laparoscopic salpingo-oophorectomy and could not avoid the artificial rupture of the tumor. Fortunately, our case had no recurrence in the abdominal cavity. However artificial rupture of the tumor should be avoided in order to prevent recurrence
. Furthermore, the previous analysis revealed that while hysterectomy, bilateral salpingo-oophorectomy and lymphadenectomy were associated with a better outcome, omentectomy did not affect the overall survival. This may suggest that the spreading pattern of malignant transformation of MCTs differs from that of epithelial ovarian cancer.
Several reports suggested that the SCC antigen, either alone or in combination with other markers, such as macrophage-colony stimulating factor (M-CSF) and carcinoembryonic antigen (CEA), should be considered useful markers for squamous cell carcinoma arising from MCTs for making a preoperative diagnosis
[10–12]. On the other hand, there has been no data regarding adenocarcinoma arising from MCTs because of the small number of cases. However, as shown in Table
1, an elevation of CEA was seen in three of the 7 cases, including our present case. Therefore, tumors markers may be useful for making a preoperative diagnosis.
MCTs might occur as a result of failure of the first meiotic division, but it is unclear how the malignant transformation of MCTs occurs. Rim et al.
 studied 11 cases of malignant transformation of MCTs and elucidated that 80% of MCTs are diagnosed in subjects who are of reproductive age. Based on that finding, Amanjit et al.
 suggested that the malignant transformation of MCTs could be related to the long-term presence of non-removed MCTs. However, the pathogenesis is still unknown, and it is unclear whether malignant transformation occurs separately or co-exists with carcinoma.
It is difficult to make a diagnosis of malignant transformation of a MCT preoperatively. MRI findings may be helpful to distinguish malignant transformation from benign neoplasms. Several reports have revealed that an important feature of the malignant transformation of MCTs was the existence of an enhanced solid component in MCTs
[15–18]. In our case, MRI was performed without gadolinium enhancement, therefore, it was difficult to determine whether the lesion was malignant.
When malignant transformation of MCTs is suspected preoperatively, enhanced MRI, intraoperative consultation and a postoperative histological diagnosis are very important.
Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Department of Obstetrics and Gynecology, Osaka Medical College
Department of Pathology, Osaka Medical College
Peterson WF: Malignant degeneration of benign cystic teratomas of the overy; a collective review of the literature.Obstet Gynecol Surv 1957, 12: 793–830. 10.1097/00006254-195712000-00001PubMedView Article
Ueda G, Fujita M, Ogawa H, Sawada M, Inoue M, Tanizawa O: Adenocarcinoma in a benign cystic teratoma of the ovary: report of a case with a long survival period.Gynecol Oncol 1993, 48: 259–263. 10.1006/gyno.1993.1044PubMedView Article
Min KJ, Jee BC, Lee HS, Kim YB: Intestinal adenocarcinoma arising in a mature cystic teratoma of the ovary: a case report.Pathol Res Pract 2006, 202: 531–535. 10.1016/j.prp.2006.03.005PubMedView Article
Fishman A, Edelstein E, Altaras M, Beyth Y, Bernheim J: Adenocarcinoma arising from the gastrointestinal epithelium in benign cystic teratoma of the ovary.Gynecol Oncol 1998, 70: 418–420. 10.1006/gyno.1998.5123PubMedView Article
Levine DA, Villella JA, Poynor EA, Soslow RA: Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary.Gynecol Oncol 2004, 94: 597–599. 10.1016/j.ygyno.2004.05.045PubMedView Article
Kushima M: Adenocarcinoma arising from mature cystic teratoma of the ovary.Pathol Int 2004, 54: 139–143. 10.1111/j.1440-1827.2004.01599.xPubMedView Article
Guney M, Oral B, Demir F, Ozsoy M, Kapucuoglu N: Mucinous adenocarcinoma arising from the gastrointestinal epithelium in benign cystic teratoma of the ovary–case report.Eur J Gynaecol Oncol 2006, 27: 304–306.PubMed
Koonings PP, Campbell K, Mishell DR, Grimes DA: Relative frequency of primary ovarian neoplasms: a 10-year review.Obstet Gynecol 1989, 74: 921–926.PubMed
Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Münstedt K: Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data.Lancet Oncol. 2008, 9: 1173–1180. 10.1016/S1470-2045(08)70306-1PubMedView Article
Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I: Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.Gynecol Oncol 2000, 77: 405–409. 10.1006/gyno.2000.5784PubMedView Article
Kikkawa F, Nawa A, Tamakoshi K, Ishikawa H, Kuzuya K, Suganuma N, Hattori S, Furui K, Kawai M, Arii Y: Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.Cancer 1998, 82: 2249–2255. 10.1002/(SICI)1097-0142(19980601)82:11<2249::AID-CNCR21>3.0.CO;2-TPubMedView Article
Miyazaki K, Tokunaga T, Katabuchi H, Ohba T, Tashiro H, Okamura H: Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary.Obstet Gynecol 1991, 78: 562–566.PubMed
Rim SY, Kim SM, Choi HS: Malignant transformation of ovarian mature cystic teratoma.Int J Gynecol Cancer. 2006, 16: 140–144. 10.1111/j.1525-1438.2006.00285.xPubMedView Article
Bal A, Mohan H, Singh SB, Sehgal A: Malignant transformation in mature cystic teratoma of the ovary: report of five cases and review of the literature.Arch Gynecol Obstet 2007, 275: 179–182. 10.1007/s00404-006-0244-xPubMedView Article
Kido A, Togashi K, Konishi I, Kataoka ML, Koyama T, Ueda H, Fujii S, Konishi J: Dermoid cysts of the ovary with malignant transformation: MR appearance.AJR Am J Roentgenol 1999, 172: 445–449.PubMedView Article
Takemori M, Nishimura R: MRI findings of an ovarian dermoid cyst with malignant transformation.Magn Reson Med Sci. 2003, 2: 105–108. 10.2463/mrms.2.105PubMedView Article
Park SB, Kim JK, Kim KR, Cho KS: Preoperative diagnosis of mature cystic teratoma with malignant transformation: analysis of imaging findings and clinical and laboratory data.Arch Gynecol Obstet 2007, 275: 25–31.PubMedView Article
Yahata T, Kawasaki T, Serikawa T, Suzuki M, Tanaka K: Adenocarcinoma arising from respiratory ciliated epithelium in benign cystic teratoma of the ovary: a case report with analyzes of the CT, MRI, and pathological findings.J Obstet Gynaecol Res 2008, 34: 408–412. 10.1111/j.1447-0756.2008.00784.xPubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.